S 2179 New Jersey Senate · 2022-2023 Regular Session

Requires Medicaid preferred drug lists to provide for coverage of buprenorphine for treatment of chronic pain.

Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
Governor
Introduced Mar 7, 2022 Last action Mar 7, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Mar 7, 2022
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
FH
Fred H. Madden, Jr.
DDemocratic
NJ
4